[
  {
    "question": "A 26-year-old female with AIDS (CD4 count: 47) presents to the emergency department in severe pain. She states that over the past week she has been fatigued and has had a progressively worse headache and fever. These symptoms have failed to remit leading her to seek care in the ED. A lumbar puncture is performed which demonstrates an opening pressure of 285 mm H2O, increased lymphocytes, elevated protein, and decreased glucose. The emergency physician subsequently initiates treatment with IV amphotericin B and PO flucytosine. What additional treatment in the acute setting may be warranted in this patient?",
    "answer": "In the acute setting, given the patient's presentation with severe headache, fever, fatigue, and the findings from the lumbar puncture (increased opening pressure, lymphocytes, elevated protein, and decreased glucose), it is likely that she is experiencing a opportunistic infection such as cryptococcal meningitis, which is common in patients with AIDS and low CD4 counts.\n\nIn addition to the treatment with IV amphotericin B and PO flucytosine, the following additional treatments may be warranted:\n\n1. **Antiretroviral Therapy (ART)**: If the patient is not already on antiretroviral therapy, it should be initiated as soon as possible to improve her immune function and overall health.\n\n2. **Corticosteroids**: If there is evidence of significant inflammation or cerebral edema, corticosteroids (such as dexamethasone) may be considered to reduce inflammation and intracranial pressure.\n\n3. **Antiemetics**: If the patient is experiencing nausea or vomiting due to her symptoms, antiemetic medications (such as metoclopramide or ondansetron) may be necessary for symptom control.\n\n4. **Pain Management**: For her severe pain, appropriate analgesics (such as acetaminophen or NSAIDs) may be necessary. If pain is refractory, opioids may be considered.\n\n5. **Fluid Management**: Given the elevated opening pressure, careful fluid management is important to avoid exacerbating intracranial pressure.\n\n6. **Monitoring and Supportive Care**: Close monitoring of her neurological status, vital signs, and laboratory values is essential. Supportive care, including hydration and nutritional support, should also be provided.\n\n7. **Consultation with Infectious Disease Specialist**: Given the complexity of her case, consultation with an infectious disease specialist may be beneficial for ongoing management and treatment strategies.\n\n8. **Neurological Evaluation**: If there are concerns about neurological deficits or worsening symptoms, a neurology consultation may be indicated for further evaluation and management.\n\nBy addressing these aspects, the patient's immediate needs can be met while also preparing for long-term management of her HIV and potential complications.",
    "true_answer": "In the acute setting, serial lumbar punctures may be warranted for this patient to manage elevated intracranial pressure."
  },
  {
    "question": "You are reviewing raw data from a research study performed at your medical center examining the effectiveness of a novel AIDS screening examination. The study enrolled 250 patients with confirmed AIDS, and 240 of these patients demonstrated a positive screening examination. The control arm of the study enrolled 250 patients who do not have AIDS, and only 5 of these patients tested positive on the novel screening examination. What is the NPV of this novel test?",
    "answer": "To calculate the Negative Predictive Value (NPV) of the novel AIDS screening examination, we need to use the following formula:\n\n\\[\n\\text{NPV} = \\frac{\\text{Number of True Negatives}}{\\text{Number of True Negatives} + \\text{Number of False Negatives}}\n\\]\n\nFrom the data provided:\n\n- **Total patients with AIDS (Positive group)**: 250\n- **Positive screening results in the AIDS group**: 240\n- **Total patients without AIDS (Negative group)**: 250\n- **Positive screening results in the non-AIDS group**: 5\n\nFrom this, we can determine the following:\n\n1. **True Positives (TP)**: The number of patients with AIDS who tested positive. This is 240.\n2. **False Negatives (FN)**: The number of patients with AIDS who tested negative. This is \\(250 - 240 = 10\\).\n3. **True Negatives (TN)**: The number of patients without AIDS who tested negative. This is \\(250 - 5 = 245\\).\n4. **False Positives (FP)**: The number of patients without AIDS who tested positive. This is 5.\n\nNow we can calculate the NPV:\n\n\\[\n\\text{NPV} = \\frac{\\text{TN}}{\\text{TN} + \\text{FN}} = \\frac{245}{245 + 10} = \\frac{245}{255} \\approx 0.9608\n\\]\n\nTo express this as a percentage, we multiply by 100:\n\n\\[\n\\text{NPV} \\approx 96.08\\%\n\\]\n\nThus, the Negative Predictive Value (NPV) of the novel AIDS screening examination is approximately **96.08%**.",
    "true_answer": "The NPV of this test is calculated as the proportion of true negatives among all negative results, 245 / (245 + 10) = 0.96."
  },
  {
    "question": "A 46-year-old Caucasian male with past medical history of HIV (CD4: 77/mm^3), hypertension, hyperlipidemia, and osteoarthritis presents to the emergency department with sudden weakness of his right hand. He reports that the weakness has gradually been getting worse and that this morning he dropped his cup of coffee. He has never had anything like this happen to him before, although he was hospitalized last year for pneumonia. He reports inconsistent adherence to his home medications, which include raltegravir, tenofovir, emtricitabine, TMP-SMX, hydrochlorothiazide, pravastatin, and occasional ibuprofen. His father died of a myocardial infarction at the age of 60, and his mother suffered a stroke at the age of 72. The patient's temperature is 102.6\u00b0F (39.2\u00b0C), blood pressure is 156/92 mmHg, pulse is 88/min, and respirations are 18/min. On neurological exam, he has 3/5 strength in the distal muscles of the right extremity with preserved sensation. His neurological exam is normal in all other extremities. What is the next best step in management for this patient?",
    "answer": "Given the patient's sudden onset of right hand weakness, gradual worsening of symptoms, and the presence of other risk factors, the next best step in management would be to perform a comprehensive evaluation to determine the cause of the weakness. This should include the following:\n\n1. **Neuroimaging**: Order an urgent brain MRI with contrast to evaluate for potential causes of the weakness, such as stroke, demyelinating disease, or other neurological conditions. A CT scan of the brain can be performed initially if MRI is not readily available.\n\n2. **Laboratory Tests**: Conduct a complete blood count (CBC), comprehensive metabolic panel (CMP), HIV viral load, and CD4 count to assess his overall health and immune status. Additionally, consider testing for electrolytes, inflammation markers (e.g., CRP, ESR), and other relevant tests based on clinical findings.\n\n3. **Neurological Consultation**: Given the neurological deficit, consult with a neurologist for further evaluation and management. The neurologist can provide expertise in interpreting imaging results and determining the need for additional diagnostic tests.\n\n4. **Assessment for Infection**: Given the patient's HIV status and recent fever, assess for possible infections that could be contributing to his symptoms. This may include cultures and additional infectious disease consultations if indicated.\n\n5. **Review of Medications**: Review the patient's medication adherence and assess for any potential drug interactions or side effects that could contribute to his symptoms.\n\n6. **Monitoring and Supportive Care**: Monitor the patient closely for any changes in his neurological status and provide supportive care as needed, including pain management for his osteoarthritis.\n\nBy following these steps, the healthcare team can work towards identifying the underlying cause of the patient's weakness and initiate appropriate treatment.",
    "true_answer": "The next best step in management is to perform a head CT to investigate the cause of neurological symptoms."
  },
  {
    "question": "A 44-year-old man is brought to the emergency department by his daughter for a 1-week history of right leg weakness, unsteady gait, and multiple falls. During the past 6 months, he has become more forgetful and has sometimes lost his way along familiar routes. He has been having difficulties operating simple kitchen appliances such as the dishwasher and the coffee maker. He has recently become increasingly paranoid, agitated, and restless. He has HIV, hypertension, and type 2 diabetes mellitus. His last visit to a physician was more than 2 years ago, and he has been noncompliant with his medications. His temperature is 37.2 \u00b0C (99.0 \u00b0F), blood pressure is 152/68 mm Hg, pulse is 98/min, and respirations are 14/min. He is somnolent and slightly confused. He is oriented to person, but not place or time. There is mild lymphadenopathy in the cervical, axillary, and inguinal areas. Neurological examination shows right lower extremity weakness with normal tone and no other focal deficits. Laboratory studies show: Hemoglobin 9.2 g/dL, Leukocyte count 3600/mm3, Platelet count 140,000/mm3, CD4+ count 56/\u03bcL, HIV viral load > 100,000 copies/mL, Serum: Cryptococcal antigen negative, Toxoplasma gondii IgG positive. An MRI of the brain shows disseminated, nonenhancing white matter lesions with no mass effect. What is the most likely diagnosis?",
    "answer": "The most likely diagnosis for the 44-year-old man with the described symptoms and findings is **HIV-associated neurocognitive disorder (HAND)**, specifically **HIV encephalitis**. \n\nHere\u2019s the reasoning behind this diagnosis:\n\n1. **HIV Infection**: The patient has a known history of HIV, and his CD4+ count is critically low (56/\u03bcL), indicating advanced immunodeficiency. This low CD4 count is a significant risk factor for developing neurological complications.\n\n2. **Neurological Symptoms**: The patient presents with right leg weakness, unsteady gait, and cognitive impairments such as forgetfulness and difficulty with simple tasks. These symptoms are consistent with HIV encephalitis, which can lead to motor deficits and cognitive decline.\n\n3. **Psychiatric Symptoms**: The patient's paranoia, agitation, and restlessness are also common in HIV encephalitis, often referred to as HIV-associated dementia (HAD) or HIV encephalopathy.\n\n4. **Laboratory Findings**: The negative Cryptococcal antigen test rules out cryptococcal meningitis, which is another potential opportunistic infection in HIV patients. The positive Toxoplasma gondii IgG indicates past exposure but does not necessarily indicate active infection.\n\n5. **MRI Findings**: The disseminated, nonenhancing white matter lesions on MRI are characteristic of HIV encephalitis and other HIV-related neurological complications.\n\nGiven the combination of the patient's HIV status, low CD4 count, neurological symptoms, and MRI findings, HIV encephalitis is the most likely diagnosis. It is crucial to initiate antiretroviral therapy (ART) promptly to manage his HIV and address his neurological symptoms.",
    "true_answer": "The most likely diagnosis is progressive multifocal leukoencephalopathy."
  },
  {
    "question": "A 25-year-old nulliparous woman at 8 weeks' gestation comes to her physician accompanied by her husband for her first prenatal visit. She has no personal or family history of serious illness. Her vaccinations are up-to-date and she takes no medications. She has no history of recreational drug use and does not drink alcohol. Her vital signs are within normal limits. She is 167 cm (5 ft 6 in) tall and weighs 68 kg (150 lb); BMI is 24.3 kg/m2. She tested negative for HIV, Chlamydia trachomatis, and Neisseria gonorrhoeae 4 years ago. What following tests should be done at this visit?",
    "answer": "At the first prenatal visit for a 25-year-old nulliparous woman at 8 weeks' gestation, several tests and assessments are typically recommended to ensure a healthy pregnancy. Here are the tests that should be considered:\n\n1. **Prenatal Blood Tests:**\n   - **Complete Blood Count (CBC):** To assess overall health, check for anemia, and evaluate blood cell counts.\n   - **Blood Type and Rh Factor:** To determine blood type and Rh status, which is important for potential Rh incompatibility issues.\n   - **Hemoglobin and Hematocrit:** To screen for anemia.\n   - **Rubella Immunity Test:** To check if she is immune to rubella (German measles), which can cause birth defects if contracted during pregnancy.\n   - **Hepatitis B Surface Antigen (HBsAg):** To screen for hepatitis B infection.\n   - **Hepatitis C Virus (HCV) Antibody Test:** To screen for hepatitis C infection.\n   - **Syphilis Screening:** To test for syphilis, which can affect the baby if left untreated.\n   - **HIV Screening:** Although she tested negative 4 years ago, it is recommended to retest during pregnancy due to the potential for transmission to the baby.\n\n2. **Urine Tests:**\n   - **Urinalysis:** To check for signs of infection, proteinuria, and glucose levels, which can indicate gestational diabetes or other issues.\n\n3. **Physical Examination:**\n   - A thorough physical examination, including a pelvic exam, to assess the reproductive system and check for any abnormalities.\n\n4. **Ultrasound:**\n   - An ultrasound may be performed to confirm the pregnancy, assess the gestational age, and check for the presence of a heartbeat.\n\n5. **Genetic Screening:**\n   - Discussion about options for genetic screening, including carrier screening for conditions like cystic fibrosis, sickle cell disease, and spinal muscular atrophy, especially if there is a family history of genetic disorders.\n\n6. **Prenatal Counseling:**\n   - Discussion about lifestyle modifications, nutrition, and any concerns the patient may have regarding her pregnancy.\n\n7. **Vaccination Update:**\n   - Assessment of her vaccination status, including the need for a tetanus, diphtheria, and pertussis (Tdap) booster during pregnancy.\n\n8. **Screening for Domestic Violence:**\n   - Routine screening for domestic violence, as it can affect the health of both the mother and the baby.\n\n9. **Assessment of Psychosocial Factors:**\n   - Evaluation of her emotional well-being and any psychosocial factors that may impact her pregnancy.\n\nBy conducting these tests and assessments, the healthcare provider can ensure a comprehensive evaluation of the mother's health and the health of the developing fetus, allowing for early intervention if any issues arise.",
    "true_answer": "Tests to conduct at this visit include ELISA for HIV, a rapid plasma reagin test, and serum HBsAg."
  },
  {
    "question": "A 33-year-old HIV-positive male is seen in clinic for follow-up care. When asked if he has been adhering to his HIV medications, the patient exclaims that he has been depressed, thus causing him to not take his medication for six months. His CD4+ count is now 33 cells/mm3. What medication(s) should he take in addition to his anti-retroviral therapy?",
    "answer": "In addition to anti-retroviral therapy (ART), the patient should consider taking medications to address his depression, which may help improve adherence to his HIV medications. Commonly prescribed antidepressants include selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine, sertraline, or escitalopram. It is important to consult with a healthcare provider to determine the most appropriate medication based on the patient's specific circumstances, potential side effects, and interactions with his current ART regimen. Additionally, the patient may benefit from counseling or psychotherapy to address his depression and improve overall mental health.",
    "true_answer": "In addition to his antiretroviral therapy, the patient should take azithromycin and trimethoprim-sulfamethoxazole to prevent opportunistic infections."
  },
  {
    "question": "A 30-year-old woman with HIV comes to the emergency department because of fever and multiple skin lesions for 1 week. She also has nausea, anorexia, and abdominal pain. The skin lesions are non-pruritic and painless. She has smoked one pack of cigarettes daily for 15 years and drinks 2 beers daily. She has been using intravenous crack cocaine for 6 years. She appears ill. Her temperature is 38\u00b0C (100.4\u00b0F), pulse is 105/min, blood pressure is 110/75 mm Hg. Her BMI is 19 kg/m2. Examination shows track marks on both cubital fossae. There are white patches on her palate that can be scraped off. There are several red papules measuring 1 to 2 cm on her face and trunk. Her CD4+T-lymphocyte count is 98/mm3 (N \u2265 500). Biopsy of a skin lesion shows vascular proliferation and small black bacteria on Warthin-Starry stain. What is the most appropriate pharmacotherapy?",
    "answer": "The patient's presentation, including her HIV status, low CD4+ T-lymphocyte count, and the characteristics of her skin lesions, strongly suggests a diagnosis of Kaposi's sarcoma (KS). The presence of vascular proliferation in the skin biopsy and the low CD4 count are indicative of KS, which is a common opportunistic infection in HIV-positive individuals, especially those with advanced immunodeficiency.\n\nGiven the diagnosis of Kaposi's sarcoma, the most appropriate pharmacotherapy would be to initiate treatment with a systemic chemotherapy agent that is effective against KS. The first-line treatment for KS in HIV-positive patients is typically a combination of antiretroviral therapy (ART) to improve immune function and chemotherapy to target the KS lesions.\n\n1. **Antiretroviral Therapy (ART)**: The patient should be started on an appropriate ART regimen to manage her HIV infection and improve her CD4 count. This is crucial for overall health and to reduce the risk of further opportunistic infections.\n\n2. **Chemotherapy for KS**: Commonly used agents for KS include:\n   - **Liposomal doxorubicin**: This is often the first-line treatment for KS due to its efficacy and manageable side effect profile.\n   - **Paclitaxel**: This can also be effective, especially in cases where liposomal doxorubicin is contraindicated or not tolerated.\n\n3. **Supportive Care**: The patient should also receive supportive care for her symptoms, including management of nausea and abdominal pain. This may include antiemetics and analgesics as needed.\n\n4. **Monitoring**: Close monitoring of her response to treatment, including regular CD4 counts and viral load measurements, is essential. Additionally, monitoring for side effects of chemotherapy is important.\n\nIn summary, the most appropriate pharmacotherapy for this patient would be to initiate an appropriate ART regimen and start chemotherapy with liposomal doxorubicin or paclitaxel, while also providing supportive care for her symptoms.",
    "true_answer": "The most appropriate pharmacotherapy for this patient is erythromycin."
  },
  {
    "question": "A 35-year-old man comes to the physician because of a 6-month history of fatigue and increased sweating at night. He says that he feels 'constantly tired' and needs more rest than usual although he sleeps well. In the morning, his sheets are often wet and his skin is clammy. He has not had any sore throat, runny nose, or cough recently. He has not traveled anywhere. Over the past 4 months, he has had a 6.8-kg (15-lb) weight loss, despite having a normal appetite. He does not drink or urinate more than usual. He is 181 cm (5 ft 11 in) tall and weighs 72 kg (159 lb); BMI is 22 kg/m2. His temperature is 37.9\u00b0C (100.2\u00b0F), pulse is 65/min, and blood pressure is 120/70 mm Hg. Physical examination shows no abnormalities. An HIV screening test and confirmatory test are both positive. The CD4 count is 600 cells/\u03bcl and the viral load is 104 copies/mL. Treatment with lamivudine, zidovudine, and indinavir is begun. The patient is at greatest risk for what adverse effects?",
    "answer": "The patient, a 35-year-old man with a positive HIV test, is being treated with a combination of antiretroviral medications: lamivudine, zidovudine, and indinavir. Each of these drugs has specific adverse effects that the patient may be at risk for:\n\n1. **Lamivudine**: Common side effects include nausea, diarrhea, and headache. Less commonly, it can lead to liver problems, especially in patients with pre-existing liver conditions.\n\n2. **Zidovudine**: This medication can cause a range of side effects, including nausea, vomiting, diarrhea, and fatigue. More serious side effects can include bone marrow suppression (leading to anemia, neutropenia, or thrombocytopenia), and lactic acidosis, which is a rare but serious metabolic complication.\n\n3. **Indinavir**: This protease inhibitor can cause gastrointestinal side effects such as nausea, vomiting, and diarrhea. It can also lead to kidney stones and crystalluria (crystals in the urine), which can cause pain and urinary tract issues. Additionally, indinavir can interact with other medications and has been associated with lipodystrophy (changes in body fat distribution) and hyperlipidemia (high cholesterol).\n\nGiven the combination of these medications, the patient is at greatest risk for gastrointestinal adverse effects (nausea, vomiting, diarrhea), as well as potential hematologic issues (like anemia) from zidovudine and renal complications from indinavir. Close monitoring of his blood counts, liver function, and renal function will be important during the course of treatment.",
    "true_answer": "The patient is at greatest risk for developing urolithiasis as an adverse effect."
  },
  {
    "question": "A 52-year-old man is brought to the emergency department because of headaches, vertigo, and changes to his personality for the past few weeks. He was diagnosed with HIV 14 years ago and was started on antiretroviral therapy at that time. Medical records from one month ago indicate that he followed his medication schedule inconsistently. Since then, he has been regularly taking his antiretroviral medications and trimethoprim-sulfamethoxazole. His vital signs are within normal limits. Neurological examination shows ataxia and apathy. Mini-Mental State Examination score is 15/30. Laboratory studies show: Hemoglobin 12.5 g/dL Leukocyte count 8400/mm3 Segmented neutrophils 80% Eosinophils 1% Lymphocytes 17% Monocytes 2% CD4+ T-lymphocytes 90/\u03bcL Platelet count 328,000/mm3 An MRI of the brain with contrast shows a solitary ring-enhancing lesion involving the corpus callosum and measuring 4.5 cm in diameter. A lumbar puncture with subsequent cerebrospinal fluid analysis shows slight pleocytosis, and PCR is positive for Epstein-Barr virus DNA. What is the most likely diagnosis?",
    "answer": "The most likely diagnosis for the 52-year-old man with HIV, given his symptoms and findings, is ** Progressive Multifocal Leukoencephalopathy (PML)**. \n\nHere's the reasoning:\n\n1. **Clinical Presentation**: The patient presents with headaches, vertigo, and changes in personality, which are common symptoms of PML. The neurological examination showing ataxia and apathy further supports this diagnosis.\n\n2. **HIV and Immunosuppression**: The patient has a long history of HIV and has been on antiretroviral therapy. His CD4+ T-lymphocyte count is 90/\u03bcL, indicating significant immunosuppression, which is a risk factor for developing PML.\n\n3. **MRI Findings**: The MRI shows a solitary ring-enhancing lesion in the corpus callosum, which is characteristic of PML. The size and location of the lesion are consistent with this diagnosis.\n\n4. **CSF Analysis**: The slight pleocytosis in the cerebrospinal fluid (CSF) and the positive PCR for Epstein-Barr virus DNA suggest an active infection, which can be associated with PML, although the presence of EBV does not confirm PML.\n\n5. **Exclusion of Other Diagnoses**: While other conditions such as primary central nervous system lymphoma or toxoplasmosis could also present with similar findings, the combination of the patient's HIV status, low CD4 count, and the specific MRI findings strongly point towards PML.\n\nIn summary, the clinical presentation, laboratory results, and imaging findings collectively support a diagnosis of Progressive Multifocal Leukoencephalopathy.",
    "true_answer": "The most likely diagnosis is CNS lymphoma."
  },
  {
    "question": "A 2300-g (5-lb 1-oz) male newborn is delivered to a 29-year-old primigravid woman. The mother has HIV and received triple antiretroviral therapy during pregnancy. Her HIV viral load was 678 copies/mL 1 week prior to delivery. Labor was uncomplicated. Apgar scores are 7 and 8 at 1 and 5 minutes respectively. Physical examination of the newborn shows no abnormalities. What is the most appropriate next step in management of this infant?",
    "answer": "The most appropriate next step in the management of this infant, given the mother's HIV status and the newborn's exposure, is to initiate post-exposure prophylaxis (PEP) for the newborn. This typically involves administering a combination of antiretroviral medications to the infant to reduce the risk of HIV transmission. Additionally, the infant should be closely monitored for signs of infection and undergo HIV testing at regular intervals, starting with an early infant diagnosis test, usually within the first few weeks of life.",
    "true_answer": "The next best step in management for this infant is to administer zidovudine."
  }
]